Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank90
5Y CAGR+94.5%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
+94.5%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
27.8x
Strong expansion
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 74.09% |
| Q2 2025 | -0.57% |
| Q1 2025 | -8.56% |
| Q4 2024 | 5.63% |
| Q3 2024 | -15.44% |
| Q2 2024 | 42.20% |
| Q1 2024 | -23.98% |
| Q4 2023 | 9.95% |
| Q3 2023 | -6.12% |
| Q2 2023 | 7.45% |
| Q1 2023 | 24.41% |
| Q4 2022 | 19.86% |
| Q3 2022 | -2.50% |
| Q2 2022 | 7.13% |
| Q1 2022 | 20.31% |
| Q4 2021 | -7.43% |
| Q3 2021 | 21.44% |
| Q2 2021 | 50.41% |
| Q1 2021 | 26.36% |
| Q4 2020 | 30.53% |
| Q3 2020 | 2.66% |
| Q2 2020 | 98.99% |
| Q1 2020 | 232.53% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 61963.23% |
| Q3 2017 | 79.64% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |